SLA2 antibody
Principal name
SLA2 antibody
Alternative names for SLA2 antibody
Src-like-adapter 2, SLAP2, SLAP-2, MARS, C20orf156, Src-like adapter protein 2, Modulator of antigen receptor signaling
Ncbi ID
9606, NP_115590, NM_032214, NP_115590.1, NM_175077, NP_084259.1, NM_029983
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Immunoprecipitation (IP), Flow Cytometry (F), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of SLA2 antibody
- Kit Component:
- - KN315843G1, Sla2 gRNA vector 1 in pCas-Guide vector
- KN315843G2, Sla2 gRNA vector 2 in pCas-Guide vector
- KN315843D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Holland S.J., Liao X.C.. et al. (2001). J. Exp. Med. 194:1263-1276
Western Blot analysis of SLA2 expression in transfected 293T cell line by SLA2 monoclonal antibody (M01), clone 3G5.Lane 1: SLA2 transfected lysate(28.454 KDa).Lane 2: Non-transfected lysate.
Detection limit for recombinant GST tagged SLA2 is approximately 0.03ng/ml as a capture antibody.
Western Blot analysis of SLA2 expression in transfected 293T cell line (H00084174-T01) by SLA2 MaxPab polyclonal antibody.Lane 1: SLA2 transfected lysate(28.71 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of SLA2 expression in transfected 293T cell line (H00084174-T01) by SLA2 MaxPab polyclonal antibody.Lane 1: SLA2 transfected lysate(28.60 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of SLA2 expression in transfected 293T cell line (H00084174-T01) by SLA2 MaxPab polyclonal antibody.Lane 1: SLA2 transfected lysate(28.60 KDa).Lane 2: Non-transfected lysate.
Immunoprecipitation of SLA2 transfected lysate using anti-SLA2 MaxPab rabbit polyclonal antibody and Protein A Magnetic Bead (U0007), and immunoblotted with SLA2 MaxPab mouse polyclonal antibody (B01) (H00084174-B01).
Human Jurkat; WB Suggested Anti-SLA2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Jurkat cell lysate; SLA2 antibody - N-terminal region (ARP60508_P050) in Human Jurkat cells using Western Blot
Human HepG2; WB Suggested Anti-SLA2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: HepG2 cell lysate; SLA2 antibody - middle region (ARP60509_P050) in Human HepG2 cells using Western Blot
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505078)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505078), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
Immunohistochemical staining of paraffin-embedded Human bladder tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505123)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505123), and then analyzed by flow cytometry.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505124), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505125)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505125)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505125)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505125), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human breast tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human kidney tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Human lung tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
Immunohistochemical staining of paraffin-embedded Human bladder tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505126)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505126), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA505127)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA505127)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
Anti-SLA2 mouse monoclonal antibody (TA505128) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SLA2(RC208103).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Human breast tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Human Ovary tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505141)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505141), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505142)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505142)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505142)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505143)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505143)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505143)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-SLA2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA505143)
Anti-SLA2 mouse monoclonal antibody (TA505143) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SLA2(RC208103).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505143), and then analyzed by flow cytometry.
Anti-SLA2 mouse monoclonal antibody (TA505152) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SLA2(RC208103).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
HEK293T cells transfected with either RC208103 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SLA2 antibody(TA505153), and then analyzed by flow cytometry.
Anti-SLA2 mouse monoclonal antibody (TA505161) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SLA2(RC208103).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2 (RC208103, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLA2.
- Quick-Filters:
- Highly Validated (6)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA505123 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI3E3 (formerly 3E3) | |||||||
 |
Mouse | IgG2b | OTI3E3 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +8 additional images |
Highly validated antibody!
|
||||||
| TA505125 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI1E7 (formerly 1E7) | |||||||
 |
Mouse | IgG2b | OTI1E7 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +4 additional images |
Highly validated antibody!
|
||||||
| TA505126 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI3A7 (formerly 3A7) | |||||||
 |
Mouse | IgG1 | OTI3A7 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +15 additional images |
Highly validated antibody!
|
||||||
| TA505141 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI1F7 (formerly 1F7) | |||||||
 |
Mouse | IgG2b | OTI1F7 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +9 additional images |
Highly validated antibody!
|
||||||
| TA505142 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI4A11 (formerly 4A11) | |||||||
 |
Mouse | IgG2b | OTI4A11 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA505143 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI2G3 (formerly 2G3) | |||||||
 |
Mouse | IgG2b | OTI2G3 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +6 additional images |
Highly validated antibody!
|
||||||
| TA505078 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI1D8 (formerly 1D8) | |||||||
 |
Mouse | IgG1 | OTI1D8 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA505124 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI1D2 (formerly 1D2) | |||||||
 |
Mouse | IgG1 | OTI1D2 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505127 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTIB2 (formerly B2) | |||||||
 |
Mouse | IgG2a | OTIB2 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA505128 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI2F11 (formerly 2F11) | |||||||
 |
Mouse | IgG1 | OTI2F11 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505152 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI3D4 (formerly 3D4) | |||||||
 |
Mouse | IgG2b | OTI3D4 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505153 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI2F7 (formerly 2F7) | |||||||
 |
Mouse | IgG1 | OTI2F7 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA505161 | SLA2 antibody |
||||||
| SLA2 mouse monoclonal antibody, clone OTI3H9 (formerly 3H9) | |||||||
 |
Mouse | IgG2a | OTI3H9 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP308103 | SLA2 (transcript variant 1) |
||||
| Recombinant protein of human Src-like-adaptor 2 (SLA2), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY406314 | SLA2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY410277 | SLA2 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR203346L2V | Lenti ORF particles, Sla2 (GFP-tagged) - Mouse Src-like-adaptor 2 (Sla2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR203346L1V | Lenti ORF particles, Sla2 (Myc-DDK-tagged) - Mouse Src-like-adaptor 2 (Sla2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
